A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing response to midostaurin

A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing response to midostaurin

Abstract Management of systemic mastocytosis is an emerging challenge which requires a multidisciplinary diagnostic approach and personalized treatment strategy. Midostaurin can rapidly reduce the disease burden, also in cladribine refractory cases.

Bibliographic Details
Main Authors: Mariarita Sciumè, Fabio Serpenti, Simona Muratori, Valerio Pravettoni, Fabio Massimo Ulivieri, Giorgio Alberto Croci, Anna Chiara Migliorini, Andrea Esposito, Maria Cecilia Goldaniga, Giorgia Natascia Saporiti, Giulia Galassi, Luca Baldini, Francesco Onida, Federica Irene Grifoni
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:Clinical Case Reports
Subjects:
bulky lymphadenopathy
midostaurin
purine analogue
systemic mastocytosis
Online Access:https://doi.org/10.1002/ccr3.3717

Internet

https://doi.org/10.1002/ccr3.3717

Similar Items